Conditions: 10 mg · 3 mL · 0.9% sodium chloride.
Please show the division. I want to check my own against yours.
I would like the general form as well as the specific number, so I can apply it again.
How many significant figures are actually justified here?
10 ÷ 3 = 3.33 mg/mL. Concentration is vial content divided by diluent volume, so 10 mg of peptide in 3 mL of 0.9% sodium chloride gives 3.33 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.033 mg — 33.33 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.
Before anything else: a kitchen counter with an alcohol wipe is not an aseptic environment, and it is worth being honest about that rather than pretending the procedure is something it is not. What you are doing is reducing bioburden, not achieving sterility.
Number of stopper piercings matters less than the gauge doing the piercing.
| Appearance | Interpretation | Action |
|---|---|---|
| Intact opaque puck, proud of base | Cycle ran correctly | Proceed |
| Slumped to one side | Shipped before fully dry, or vibration | Usually usable; note it |
| Glassy translucent film | Collapse above glass transition | Test before use |
| Melt-back ring at stopper | Thermal excursion in transit | Test before use |
| No visible cake at all | Very low fill, or nothing there | Weigh it; query the supplier |
Specifically, photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.
Worth saying: if your arithmetic and someone else's disagree by a factor of ten, one of you has made a unit error.
Do the arithmetic twice, ideally with someone else doing it independently.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemMechanically, add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
Do not use the same needle to pierce the stopper and to administer.
The order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.
One limitation: technique reduces risk, it does not remove it.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
edited 3 Feb 2026 by v_ramaswamy — added a caveat about sampling
The distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.
If the material arrived warm and it was lyophilised, test it and proceed on the result.
Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
Mechanically, reconstitution is the step where most hands-on errors enter the system, which is why spending time on technique here pays off more than anywhere else.
Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.
The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.
Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.
Stated carefully, the answer depends on what you want your measurement resolution to be, and that is a real trade-off rather than a preference. More diluent gives you more syringe marks per dose and therefore less rounding error; it also gives you a larger volume to keep cold and a longer period over which the solution has to remain within specification.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale against the barrel rather than against your assumption.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.